Repare Therapeutics Inc (RPTX) Company Profile & Statistics

Repare Therapeutics Inc
RPTX
(Nasdaq - US)
N/A
3.28
-0.12 (-3.53%)
in:usd•As of: May 07, 2024 15:59 UTC -4
After Market:3.34+0.06 (+1.83%)
Open
3.37
High
3.39
Low
3.28

About Repare Therapeutics Inc

CEO

Lloyd M. Segal

Headquarters

7171 frederick-banting, building 2, suite 270

st-laurent, a8 h4s 1z9, canada

Auditor

Ernst & Young LLP

Employees

179

Share Holders

Website

www.reparerx.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Repare Therapeutics Inc. is an oncology company. It utilizes genome-wide, CRISPR-enabled SNIPRx(R) platform to discover and develop targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company's product pipeline includes RP-3500, which is in clinical stage. Repare Therapeutics Inc. is based in St-Laurent, Canada.

Repare Therapeutics Inc Statistics

Valuation Measures

Market Capitalization ²	139.20M
Enterprise Value	27.94M
Enterprise Value/EBITDA (ttm)	-0.23
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.69
Price to Sales (ttm)	2.86
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	100.00%
Operating Margin (ttm)	-183.43%
Profit Margin (ttm)	-436.03%
Return on Equity (ttm)	-39.82%
Return on Invested Capital (ttm)	-40.08%
Return on Assets (ttm)	-31.84%

Income Statement

Revenue (ttm)	51.13M
Revenue Per Share (ttm)	1.21
Gross Profit (ttm)	51.13M
EBITDA (ttm)³	-121.74M
Net Income Avi to Common (ttm)	-93.80M
Diluted EPS (ttm)	-2.23

Share Statistics

Beta (5Y Monthly)	0.70
52-Week Change	-68.52%
S&P500 52-Week Change	27.90%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	42.18M
Dividend Yield	0.00%
Float ⁴	30.35M
% Held by Insiders	28.50%
% Held by Institutions	85.09%

Balance Sheet

Total Cash (mrq)	223.63M
Total Cash Per Share (mrq)	5.30
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	6.24%
Quick Ratio (mrq)	6.24%
Book Value Per Share (mrq)	5.03

Cash Flow

Operating Cash Flow Per Share (ytd)	-3.02
Free Cash Flow (ytd)	-129.10M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Repare Therapeutics Inc

Trade With A Regulated Broker